TENX → $35.00 by Dec 9, 2026.

Shares are currently trading at $1.95 with the market cap currently at 72.98M Today, Cantor comes blazing in and reiterates with an overweight rating and $35 price target! Add the fact that expert bio investor Dr. Daniel Schneeberger recently added heavily to his existing position with Adar1 Capital Management and now his shares total 6,524,151 to date. Details from the presentation yesterday at the 2026 Cantor Global Healthcare Conference $TENX What we confirmed • Oral levosimendan is safe and well-tolerated …